Clinical trial · Interventional
Development of Clinical and Biological Database on Bronchial Cancer
Development of a Prospective Monocentric Clinico-Biological Database for Bronchial Cancer
NCT07085429CI-TRIAL-00092590BCBPoumonnot yet recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A Clinical and Biological Database will provide to the scientific community a collection of blood and tissues with clinical data to improve knowledge about cancer and help to develope new cancer treatments. This database is specific to bronchial cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bronchial Cancer | — | UNRESOLVED | — |
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood and tissue sampling | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Bronchial cancer
- description
- Additionnal samples from routine care of different natures (blood, tumor tissue ans healthy tissue) and standardized clinical data will be entered into a database.
- interventionNames
- Biological: Blood and tissue sampling
Primary outcomes (1)
- measure
- Proportion of patients who consent to participate in the study
- timeFrame
- through study completion : an average of 1 year
- description
- the proportion of patients who consent to participate in the study among the screened patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female patient aged over 18 years, * Histologically or cytologically confirmed bronchial cancer, * Treatment-naïve patient for the current cancer, * Patient who has provided informed, written, and explicit consent, * Patient affiliated with the French national health insurance system. Exclusion Criteria: * Patient with a WHO performance status ≥ 3, * Pregnant and/or breastfeeding woman, * Patient with a history of other cancers within the 5 years preceding inclusion, * Patient for whom regular follow-up is considered impossible due to psychological, familial, social, or geographic reasons, * Patient under legal protection (guardianship, curatorship, or judicial protection).
References
Publications (0)
Data not yet available
No reference posted for this study.